Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis.
ANCA vasculitis
Granulomatosis with polyangiitis
Microscopic polyangiitis
Treatment
Journal
Rheumatic diseases clinics of North America
ISSN: 1558-3163
Titre abrégé: Rheum Dis Clin North Am
Pays: United States
ID NLM: 8708093
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
medline:
20
6
2023
pubmed:
19
6
2023
entrez:
18
6
2023
Statut:
ppublish
Résumé
We have made significant headway in our ability to induce and maintain remission in patients with granulomatosis with polyangiitis and microscopic polyangiitis. With increased understanding of the pathogenesis of antineutrophilic cytoplasmic antibody-associated vasculitides (AAV), therapeutic targets have been identified and studied in clinical trials. From initial induction strategies including glucocorticoids and cyclophosphamide, we have discovered effective induction regimens with rituximab and complement inhibition that can significantly decrease the glucocorticoid cumulative doses in patients with AAV. There are many trials underway evaluating management strategies for refractory patients and exploring new and old therapies that may help to continuously improve outcomes for patients with AAV.
Identifiants
pubmed: 37331732
pii: S0889-857X(23)00035-2
doi: 10.1016/j.rdc.2023.03.004
pii:
doi:
Substances chimiques
Rituximab
4F4X42SYQ6
Antibodies, Antineutrophil Cytoplasmic
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
545-561Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.